Skip to main content
Skip to McMaster Navigation Skip to Site Navigation Skip to main content
McMaster logo
COVID-19 information and updates

Find the most recent updates here, as well as FAQs and information for students, faculty and staff.

Why Canada should introduce universal drug coverage

In a new article on The Conversation, Political Science Professor Katherine Boothe examines the idea that pharmacare is fundamentally “unaffordable,” and the lack of evidence to support it.

Jun 27, 2017

Professor Katherine Boothe discusses the problems caused by a lack of universal public drug coverage in Canada, and the longstanding political consensus that pharmacare would be “too expensive” here. She surveys recent research that suggests this is not the case, and that universal pharmacare could result in lower drug costs overall, and fewer barriers to Canadians accessing the drugs they need. 

Full article featured on The Conversation.